Us Congress 2023-2024 Regular Session

Us Congress House Bill HB2812

Introduced
4/25/23  
Refer
4/25/23  
Report Pass
4/26/23  

Caption

Middle Market IPO Cost Act

Impact

The findings of the study required by HB 2812 are expected to have significant implications for state laws regarding securities and capital formation for businesses. By evaluating how IPO costs compare to alternative financing options, the SEC’s report may catalyze legislative actions aimed at reducing the financial burdens on companies looking to go public. The promotion of a healthier IPO market for small- and medium-sized enterprises (SMEs) has the potential to invigorate economic growth and job creation in various sectors where these businesses operate.

Summary

House Bill 2812, known as the Middle Market IPO Underwriting Cost Act, mandates that the Securities and Exchange Commission (SEC) conduct a comprehensive study on the costs associated with small- and medium-sized companies undertaking initial public offerings (IPOs). This bill aims to assess both the direct and indirect expenses incurred during the IPO process, including underwriter fees, compliance costs with federal and state laws, and other relevant expenses. Through this investigation, the bill seeks to illuminate the financial barriers these companies face in accessing public markets for capital, which is critical for their growth and sustainability.

Sentiment

The sentiment surrounding HB 2812 is largely positive among proponents, who view the bill as a crucial step in fostering a more equitable environment for small businesses in the financial markets. Supporters argue that the increased transparency regarding the costs associated with IPOs will empower these companies, enhancing their ability to make informed decisions about capital raises. Meanwhile, some skepticism exists about whether the study will lead to actionable change or merely serve as a means of gathering data without resulting in meaningful reforms.

Contention

While the bill has garnered support for its focus on small businesses, there are concerns about the depth and effectiveness of the study it mandates. Critics voice apprehension that the effort may not adequately address the complexities of capital formation and regulatory compliance. Additionally, some stakeholders worry that focusing on IPO costs may inadvertently shift attention away from other pressing issues faced by SMEs, such as access to venture capital and market competition. This debate highlights the ongoing struggle to balance regulatory oversight with the need to facilitate business growth.

Companion Bills

No companion bills found.

Previously Filed As

US HB3395

Middle Market IPO Cost Act

US HB2798

CFPB Transparency and Accountability Reform Act Transparency in CFPB Cost-Benefit Analysis Act CFPB Dual Mandate and Economic Analysis Act CFPB Whistleblower Incentives and Protection Act Making the CFPB Accountable to Small Businesses Act of 2023 CFPB–IG Reform Act of 2023 Bureau of Consumer Financial Protection-Inspector General Reform Act of 2023 TABS Act of 2023 Taking Account of Bureaucrats’ Spending Act of 2023

US HB4767

Protecting Americans’ Retirement Savings from Politics Act

US HB896

Truth in Healthcare Marketing Act of 2023

US HB2799

Expanding Access to Capital Act of 2023

US SB1967

PBM Act Patients Before Middlemen Act

US HB5315

Rural Forest Markets Act of 2023

US HB2598

Preparing Regulators Effectively for a Post-prohibition Adult-use Regulated Environment Act of 2023 PREPARE Act of 2023

US HB4237

Ensuring Sound Guidance Act

US HB2646

John Tanner and Jim Cooper Fairness and Independence in Redistricting Act

Similar Bills

No similar bills found.